Online / Physical Event

8th World Congress & Exhibition on

Vascular Surgery

Theme: Exploring New Frontiers in Vascular Surgery

Event Date & Time

Event Location

London, UK

Brochure Program Abstract Registration ReaderBase Awards

20 Years Of Excellence in Scientific Events

442039912223

Performers / Professionals From Around The Globe

Conference Speaker

Harivadan Lukka

Venkateshwara Vascular Foundation
India

Conference Speaker

Saliha G Karakelle

Istanbul University-Cerrahpasa
Turkey

Conference Speaker

Ulf Thorsten Zierau

Saphenion
Germany

Conference Speaker

Patrick Kelly

Standford Healthcare
USA

Conference Speaker

Andres Ramon Martinez C

Eastern National University
Paraguay

Conference Speaker

Claudia Hidasy

Hospital Quinta D`Or
Brazil

Tracks & Key Topics

vascularsurgery 2022

About Conference

Vascular Surgery 2022 with immense pleasure invites all the contributors across the globe to our Webinar on 8th Edition of World Congress & Exhibition on Vascular Surgery during October 24-25, 2022 at London, UK which includes prompt keynote presentations, oral talks, poster presentations and exhibitions. Euroscicon LTD organizes 1000+ scientific events inclusive of 600+ conferences, 500+ workshops and 200+ symposiums on various topics of science & technology across the globe with support from 1000 more scientific societies and publishes 500+ open access journals which contain over 50000 eminent personalities, reputed scientists as editorial board members.

Vascular surgery deals with the diagnosis and sub-surgical procedures for the management and treatment of disorders/diseases related to the vascular system, i.e. veins, arteries and the lymphatic system, excluding the coronary and intracranial arteries. A vascular surgeon is concerned with treating the blood vessels of the body including arms, legs, organs and other tissues of the body, except that of heart and brain. Vascular surgery is advised when a vascular disease cannot be treated by less invasive or non-surgical methods. The purpose of vascular surgery is to treat those diseases related to veins and arteries known as arterial and venous diseases.

Vascular diseases are caused due to the conditions like clotting of blood in blood vessels, weaken blood vessels or damaged valves which control the flow of blood within the veins thus depriving of vital nutrients and oxygen. Common vascular diseases are atherosclerosis, aortic aneurysms, peripheral vascular disease, carotid artery disease. Surgery is often suggested to treat such diseases to aid prevent strokes or heart attacks, relieve angina or hypertension, eradicate aneurysms, improve claudication by repairing the arteries, bypassing, or replacing them. Atherosclerosis i.e., the hardening of arteries occurs as people age due to the accumulation of fatty material containing cholesterol or calcium on the innermost layer of artery; cause the narrowing of the inside diameter of the blood vessels.

Sessions/Tracks

Track 1: Vascular Trauma

The term ‘vascular trauma’ refers to damage or injury to a blood vessel- an artery, which carries blood away from the heart, or a vein, which carry blood back to the heart from different organs. These injuries are categorized by the type of trauma that cause them: blunt or penetrating injury.

• Blunt injury can occur if a blood vessel is crushed or stretched.

• penetrating injury can occur if a blood vessel is punctured, torn or severed.

Both the types of vascular trauma can cause the blood vessel to clot (thrombosis) and interrupt blood flow to an organ, or cause bleeding, leading to life-threatening hemorrhage.

Vascular trauma results from a wide range of causes:

Injury (accidents, falls, cuts, etc.)

Violence

Pinching of a vein or artery

Dislocation of a bone

Piercing of a vein, such as with insertion of an IV.

Vascular injury has two main consequences- hemorrhage and ischemia. Unrecognized and uncontrolled hemorrhage can lead to demise of the trauma patient while unrecognized and untreated ischemia can lead to stroke, limb loss, bowel necrosis and multiple organ failure.

Track 2: Venous Surgery

Chronic Venous Insufficiency and Varicose veins are the most frequent blood vessel abnormalities occurring in people and affects approximately one third of the population. The treatment of these disorders depends on many factors. Mild and moderate symptoms can be successfully treated with the use of compression stocking therapy but for severe symptoms medical surgeries are done either to remove varicose veins or to close them which includes: Vein stripping, Vein ablation, Sclerotherapy, Laser Surgery, Endoscopic Vein Surgery, Ambulatory Phlebectomy.

Track 3: Vascular Diseases of the Lower Limbs

Vascular diseases of the lower limb include: Peripheral Arterial disease of the legs and Chronic Arterial Insufficiency of the lower extremities.  PAD is the condition of blood vessels that supply the legs and feet. It includes the narrowing and hardening of the arteries that results in decreased blood flow, which can injure nerve and other tissues. This problem occurs due to the buildup of fatty material (plaque) on the inside wall of arteries. Plaque is made up of extra cholesterol, calcium in blood. Blood carries the oxygen to the lower extremities but plaque buildup starves the tissues and muscles in lower limb. The underlying mechanism is usually atherosclerosis. The main risk factors include cigarette smoking, diabetes, high blood cholesterol and high blood pressure.

Track 4: Carotid Artery Disease

The carotid arteries are the blood vessels (coronary arteries) that carry oxygenated blood to the head, brain and face. They are located on each side of the neck. These arteries supply oxygen-rich blood to the large front part of the brain which control thought, personality, speech, as well as our sensory and motor functions. Carotid Artery disease occurs due to the narrowing of these arteries mostly due to atherosclerosis (plaque buildup). These plaques may break and block smaller arteries in the brain. The arteries are the source of oxygenated blood to the brain but this blockage interrupts the blood flow thus increasing the risk of stroke. A stroke can cause lasting brain damage, long-term disability, such as vision, speech problems or paralysis; or death.

Track 5: Vascular Disease of Upper Limb

Upper extremity vascular disease is relatively uncommon compared to lower extremity vascular disease but represents a unique diagnostic challenge for the physicians. The most common causes of upper extremity vascular disease are atherosclerosis and Embolic disease, but there are other systemic diseases and anatomic abnormalities such as vasculitis, arteritis, Takayasu’s Arteritis, Thoracic Outlet Compression Syndrome, Acute occlusive arterial disease and Aneurysm of upper limb artery. Some of the typical symptoms of upper extremity vascular disease include: discomfort or pain in arms, tightness, heaviness, weakness or cramping in one or both arms.

Track 6: Abdominal Aortic Aneurysms

An Abdominal Aortic Aneurism (AAA) is an enlarged area in the lower part of the aorta- the major blood vessel that supplies blood from the heart up to head and arms and down to abdomen, legs and pelvis. As aorta is the body’s main supplier of blood, a ruptured abdominal aortic aneurysm can cause life threatening bleeding. Large aneurysms are rare but are usually fetal. The bulging occurs when the walls of the aorta weakens. The reason of weakness is thought to be smoking, high blood pressure, high cholesterol level. Rupture of the abdominal aorta may result in pain in the abdomen, low blood pressure or loss of consciousness and often results in death. AAA most commonly occurs in men over 50 years of age and among those with a family history. Surgery is normally recommended with enlarged AAA, and repair may be either by open surgery or Endovascular Aneurysm Repair (EVAR).

Track 7: Thoracic Aortic Vascular Surgery

Thoracic Aortic Aneurysm is an expansion or ballooning of a section of aorta within the chest (thorax) that slowly degenerates. Thoracic Aortic Aneurysms are rare, occurring in approximately 6-10 per every 100,000 people. Surgery is often suggested if the risk of rupture is higher. The procedure for Thoracic Aortic Vascular Surgery is called Thoracic Endovascular Aortic Repair (TEVAR). To fix the aorta, a device made of a fabric- covered metal mesh known as stent graft is inserted through a small hole. The device repairs the diseased aorta, helps to keep it open and allows blood to flow easily to rest of the body. The alternative to TEVAR is refer to as ‘open repair’, which requires a large incision through the breastbone or side of the chest.

Track 8: Thoracoabdominal Aortic Vascular Surgery

Thoracoabdominal Aortic Aneurysm (TAAA) refers to the abnormal widening of the aorta involving both the thoracic and abdominal segments. These aneurysms are primarily the results of age related degeneration and weakening of the aortic wall. Elective surgical interventions are considered when the aortic size exceeds 5-6 cm. There are three surgical operative techniques for TAAA repair: open, endovascular and hybrid.

Open TAAA repair involves surgical removal of the diseased section of the aorta and replacing it with an artificial graft by making an incision extending from the upper back on the left side, curving around under the shoulder blade around to the front of abdomen.

Endovascular approach includes much less invasion with small incisions to access the blood vessels in the groin. A catheter is inserted and is used to deploy a stent graft within the aneurysm.

Hybrid approach uses a combination of the two techniques.

Track 9: Surgery for Veins and Lymphatic Diseases

Thrombolytic therapy, surgical thrombectomy, and placement of inferior vena cava filters are adjunctive treatments that can be suggested for patients with extensive and complicated venous thromboembolism. For patients with saphenous vein valvular insufficiency vein stripping, endovenous laser treatment and radiofrequency ablation therapies are implemented. Concomitant varicose veins may be managed with compression therapy, sclerotherapy and phlebectomy.

Track 10: Vascular Imaging

Vascular imaging is a test that enables to access and evaluate the body’s circulatory system and help identify blockages in veins and arteries and detect blood clots. Non-optical methods that are widely used for vascular images includes X-ray/CT, MRI, ultrasound and positron emission tomography. These techniques are most popularly used for macrovascular imaging but due to poor spatial contrast these are not effective for microvascular imaging. Optical methods recommended for microvascular imaging are single-photon fluorescence microscopy (1PFM), two-photon fluorescence microscopy, orthogonal polarization spectral imaging (OCSI), laser speckle contrast imaging (LSCI), diffusive imaging, diffuse optical tomography, etc.

Track 11: Vascular Malformations

Vascular malformations are abnormal clusters of blood vessels that occur during fetal development. These malformations are thought to result from developmental errors during embryogenesis such as abnormal signaling processes that control apoptosis, maturation and growth of vascular cells. Although these kinds of lesions are present at birth, they may not be visible until weeks or several years but typically grow in proportion to the growth of the child. Vascular malformations are characterized under four types based on their flow characteristics: slow flow (capillary malformationsvenous malformation, lymphatic malformation) and fast-flow (arteriovenous malformation). Proper identification and multidisciplinary approach is paramount for proper treatment.

Track 12: Acute Limb Ischaemia/Limb Ischaemia

Acute limb ischaemia is defined as a sudden decrease in limb perfusion that results in potential threat to the viability of the limb. It results from a sudden obstruction in the arterial flow mainly due to embolism or thrombosis and rarely by dissection or trauma. The occurrence of this case is almost 1.5 cases per 10,000 persons per year. Symptoms begins over a period of hours or days from new or worsening intermittent claudication to pain in foot or leg, muscle weakness, and paralysis of the affected limb. The rapid onset of limb ischemia results from sudden blockage of blood supply and nutrients to tissues and nerves of the limb; threatening limb viability due to insufficient time for new blood vessel growth to compensate for loss of perfusion. The primary intervention for acute limb ischemia is emergency embolectomy or vascular bypass to route the blood flow.

Track 13: Renovascular Surgery

Renal artery is the vessel through which blood passes to the kidney to remove the body’s waste. These renal arteries originate in the heart and are also responsible for carrying oxygenated blood to the kidneys. Like other arteries the renal arteries also become blocked, the condition which is called renal artery stenosis. These arteries are affected due to several diseases such as atherosclerosis, renal artery aneurysm, fibromuscular dysplasia and vasculitis. Decreased blood flow to the kidneys often lead to hypertension. If untreated, renovascular hypertension may lead to cardiovascular and kidney problems. Treatments for renovascular hypertension refer to restore the normal blood flow to the kidney. This may be done by balloon angioplasty, use of stent to keep the artery open. Surgical technique in case of atherosclerosis include endarterectomy or bypass grafting.

Track 14: Mesenteric Ischemia

Market Analysis

Global Vascular Surgery Minimally Invasive Surgical Instruments market is a growing market in Healthcare, Pharmaceuticals sector at present years. The Vascular Surgery Minimally Invasive Surgical Instruments has uncovered rapid development in the current and past years and is probably going to proceed with a continuing development in the upcoming years.

The minimally invasive surgical instruments market is projected to reach USD 21.47 Billion by 2021 from USD 13.89 Billion in 2016, at a CAGR of 9.1%. Benefits of minimally invasive surgeries over traditional open surgeries; reduction in healthcare costs and time; increasing number of surgeries among the aging population; increasing prevalence of lifestyle disorders; and technological advancements are key factors expected to drive the growth of the market. Increasing awareness of technologically advanced MIS instruments & procedures and emerging markets provide significant growth opportunities for the market.

This report segments the global minimally invasive surgical instruments market by product, application, end user, and region. The global market, by product, includes handheld instruments, electrosurgical instruments, inflation systems, guiding devices, auxiliary instruments, and cutter instruments. In 2015, the handheld instruments segment accounted for the largest share of the global market. These instruments are convenient to use and are widely implemented in almost all kinds of MIS surgeries; these factors contribute to their largest share in the MIS instruments marketWorldwide Vascular Surgery Minimally Invasive Surgical Instruments market is predominantly classified on the basis of leading marketing players, product types, applications and worldwide regions covering North America, South America, Africa and Middle East, Europe and Asia-Pacific

On the basis of end users, the global minimally invasive surgical instruments market report is segmented into government hospitals, private hospitals & surgical clinics, and academic and research institutes. In 2015, the private hospitals and surgical clinics segment accounted for the largest share of the global market. The growth of this end-user segment can be attributed to the high hygienic standards of private hospitals, low chances of contracting hospital-acquired infections, presence of cutting-edge equipment and ICUs, and timely check-ups. Therefore, the increasing adoption of minimally invasive surgeries in private hospitals and surgical clinics will increase the usage of MIS instruments, hence leading to its growth.

Conference Image

The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. In 2015, North America accounted for the largest share of the global minimally invasive surgical instruments market primarily due to the rising number of surgical procedures, growing government investments, growing geriatric population, and rising prevalence of lifestyle diseases in this region. With the rising geriatric population, presence of a large patient pool undergoing surgical treatments, growing awareness about modern surgical instruments and techniques, and implementation of various initiatives to reduce the rising healthcare expenditure in Asia-Pacific, the demand for minimally invasive surgical instruments in this region is expected to grow, which in turn will compel the key players to expand their geographical presence in this region.

Major players in the global minimally invasive surgical instruments market are Medtronic plc (Ireland), Ethicon, Inc. (U.S.), Aesculap, Inc. (Germany), Stryker Corporation (U.S.), and Smith & Nephew (U.K.). These players have a strong presence in major as well as emerging markets. Other players in this market are ConMed Corporation (U.S.), Abbott Laboratories (U.S.), Applied Biomedical Resources Corporation (U.S.), Microline Surgical (Japan), and Zimmer Biomet (U.S.).

Past Conference Report

Surgery Conferences team hosted the “Vascular Surgery 2021”, during November 29-30, 2021 online with the theme, “New & Emerging Techniques in Vascular Surgery”, which was a great success. Eminent keynote speakers from various reputed institutions and organizations addressed the gathering with their resplendent presence.

We extend our grateful thanks to all the momentous speakers, conference attendees who contributed towards the successful run of the conference.

Vascular Surgery 2020 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various latest and exciting innovations in all areas of Vascular Surgery.

Vascular Surgery 2020 Organizing Committee extends its gratitude and congratulates the Honorable Moderators of the conference.

Vascular Surgery team extends its warm gratitude to all the Honorable Guests and Keynote Speakers of “Vascular Surgery 2020”.

  • Omar Mutlak, Imperial College London, UK
  • Ottorino Del Foco, Abu Dhabi Stem Cells Center, UAE
  • Vakhtang Shoshiashvili, TSMU first university clinic. Research institute of clinical medicine, Georgia
  • Andres Ramon Martinez Cardozo, Universidad Nacional del Este, Paraguay
  • Yopie Afriandi Habibie, Universitas Syiah Kuala, Indonesia

Vascular Surgery team is privileged to felicitate Vascular Surgery 2020 Organizing Committee, Keynote Speakers, Chairs and also the Moderators of the conference whose support and efforts made the conference to move on the path of success. Surgery Conferences team thanks every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Vascular Surgery, Anesthesia.

Surgery Conferences team is glad to announce its “7th Edition of World Congress & Exhibition on Vascular Surgery” which will be held during November 29-30, 2021 with the theme, “New & Emerging Techniques in Vascular Surgery”. We cordially welcome all the eminent researchers, Presidents, CEO’s, Vascular Surgery researchers, industrialists, Surgeons, doctors, young scientists, Training Institutes, Young researchers, Data Management Companies, Hospital General Counsel, Legal Nurse Consultants, Manufacturing Medical Devices Companies, students and delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Vascular Surgery with 20% abatement on the Early Bird Prices.

Bookmark your dates for “Vascular Surgery 2022” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Talk to Us

Speak directly to one of our conference representatives by calling.


+0044-2033180199

Mail Us

E-mail us your questions about the conference. We will respond to your questions.


contact@euroscicon.com

Contact Us

Have questions?
We'll be in touch within 24 hours.


Contact Us

Address

EuroSciCon Ltd
35 Ruddlesway,
Windsor, Berkshire,
SL4 5SF, UK

EuroSciCon Events are produced by Euroscicon Ltd

EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International will issue Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.